Reduction of femoral artery bleeding post catheterization using a collagen enhanced fibrin sealant

Area of Science:

• Cardiovascular Medicine
• Biomaterials Science
• Surgical Hemostasis

Background:

• Cardiac catheterization procedures are increasing, leading to higher complication rates and healthcare costs.
• Femoral artery access is common but associated with bleeding risks.
• Effective hemostasis at the arterial puncture site is crucial for patient safety and efficient procedures.

Purpose of the Study:

• To evaluate the efficacy of a novel collagen-enhanced fibrin sealant (Collaseal) for achieving rapid hemostasis.
• To assess the potential of Collaseal to reduce bleeding complications following femoral artery catheterization.
• To explore the implications of Collaseal use for patient outcomes and healthcare economics.

Main Methods:

• A study was conducted on nine anticoagulated dogs undergoing femoral artery catheterization.
• Collaseal was applied to the arterial puncture site in treated groins, serving as a comparison to control groins.
• Bleeding was assessed, and statistical analysis was performed to compare outcomes between sealant-treated and control groups.

Main Results:

• A statistically significant reduction in gross bleeding was observed in the Collaseal-treated groins compared to control groins (P = .0156).
• The study demonstrated the sealant's effectiveness in achieving rapid hemostasis in a canine model.
• Specific bleeding signs were quantified, showing a clear benefit of the sealant application.

Conclusions:

• Collagen-enhanced fibrin sealant (Collaseal) shows promise for effective hemostasis after femoral artery catheterization.
• The findings suggest Collaseal may be a valuable tool for reducing complications, hospital stays, and costs associated with cardiac catheterization.
• Further investigation in human patients is warranted to confirm these beneficial effects.